Order Article Reprints

Fois M, De Vito A, Cherchi F, Ricci E, Pontolillo M, Falasca K, Corti N, Comelli A, Bandera A, Molteni C, et al. Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort. Antibiotics. 2024; 13(7):616. https://doi.org/10.3390/antibiotics13070616

Fois, Marco, Andrea De Vito, Francesca Cherchi, Elena Ricci, Michela Pontolillo, Katia Falasca, Nicolò Corti, Agnese Comelli, Alessandra Bandera, Chiara Molteni, and et al. 2024. "Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort" Antibiotics 13, no. 7: 616. https://doi.org/10.3390/antibiotics13070616

Fois, M., De Vito, A., Cherchi, F., Ricci, E., Pontolillo, M., Falasca, K., Corti, N., Comelli, A., Bandera, A., Molteni, C., Piconi, S., Colucci, F., Maggi, P., Boscia, V., Fugooah, A., Benedetti, S., De Socio, G. V., Bonfanti, P., & Madeddu, G. (2024). Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort. Antibiotics, 13(7), 616. https://doi.org/10.3390/antibiotics13070616